Article
Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice.
Carcinogenesis - 1 Apr 1999
McEntee M F, Chiu C H, Whelan J
Abstract excerpt
Non-steroidal anti-inflammatory drugs (NSAIDs) can cause regression of early intestinal tumors and although this is believed to involve cyclooxygenase-2 and apoptosis, the molecular mechanisms remain unclear. Cytoplasmic and nuclear beta-catenin are overexpressed in many of these lesions and Bcl-2, which inhibits apoptosis, may also be elevated during the course of intestinal tumorigenesis. We recently showed...
Topics
- Adenoma
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
- Apoptosis
- Colonic Neoplasms
- Cyclooxygenase 2
- Cytoskeletal Proteins
- Enzyme Induction
- Gene Expression Regulation, Neoplastic
- Genes, APC
- Genetic Predisposition to Disease
